Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 19, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Overview of informatics for high content screening.

R Terry Dunlay1, Wallace J Czekalski, Mark A Collins

  • 1Sage Sciences, Inc., Albuquerque, NM, USA.

Methods in Molecular Biology (Clifton, N.J.)
|September 22, 2006
PubMed
Summary

High content screening (HCS) generates vast data. Informatics tools are crucial for transforming this data into actionable knowledge for drug discovery and systems biology research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The HCS data challenge.

Drug discovery today·2013
Same author

Cell-based screening using high-throughput flow cytometry.

Assay and drug development technologies·2010
Same author

Generating 'omic knowledge': the role of informatics in high content screening.

Combinatorial chemistry & high throughput screening·2009
Same author

Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.

Journal of medicinal chemistry·2005
Same author

Novel pyrrole-containing progesterone receptor modulators.

Bioorganic & medicinal chemistry letters·2004
Same author

3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.

Journal of medicinal chemistry·2003

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Drug Discovery Informatics

Background:

  • High content screening (HCS) generates large datasets in drug discovery and systems biology.
  • Effective data analysis is essential for extracting meaningful information from HCS outputs.
  • Informatics plays a critical role in managing and interpreting complex biological data.

Purpose of the Study:

  • To provide an overview of informatics tools and technologies for HCS.
  • To discuss challenges associated with managing large volumes of HCS data.
  • To offer guidance on selecting and utilizing HCS informatics solutions.

Main Methods:

  • Review of current informatics tools and technologies applicable to HCS.
  • Discussion of data management and analysis strategies for high content data.
  • Exploration of challenges in HCS data integration and interpretation.

Main Results:

  • Identification of key informatics solutions for HCS data analysis.
  • Highlighting the importance of efficient data transformation from raw data to knowledge.
  • Addressing the need for cost-effective and efficient HCS informatics strategies.

Conclusions:

  • Informatics is indispensable for leveraging HCS data in biological research and drug development.
  • Overcoming data volume challenges requires strategic implementation of informatics tools.
  • Selecting the right informatics solution is vital for maximizing the value of HCS investments.

More Related Videos

Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Related Experiment Videos

Last Updated: Jul 19, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016